994 related articles for article (PubMed ID: 32586342)
1. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
2. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
Huang Q; Miller MR; Schappet J; Henry MD
Cancer Biol Ther; 2015; 16(1):125-36. PubMed ID: 25455932
[TBL] [Abstract][Full Text] [Related]
3. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
[TBL] [Abstract][Full Text] [Related]
4. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
6. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
8. LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.
Inamori KI; Beedle AM; de Bernabé DB; Wright ME; Campbell KP
Glycobiology; 2016 Dec; 26(12):1284-1296. PubMed ID: 27496765
[TBL] [Abstract][Full Text] [Related]
9. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
[TBL] [Abstract][Full Text] [Related]
10. Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1.
Dunbar K; Valanciute A; Lima ACS; Vinuela PF; Jamieson T; Rajasekaran V; Blackmur J; Ochocka-Fox AM; Guazzelli A; Cammareri P; Arends MJ; Sansom OJ; Myant KB; Farrington SM; Dunlop MG; Din FVN
Cell Mol Gastroenterol Hepatol; 2021; 11(2):465-489. PubMed ID: 32971322
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.
Richards S; Walker J; Nakanishi M; Belghasem M; Lyle C; Arinze N; Napoleon MA; Ravid JD; Crossland N; Zhao Q; Rosenberg D; Rahimi N; Chitalia VC
Am J Pathol; 2020 Mar; 190(3):602-613. PubMed ID: 32113662
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.
Miller MR; Ma D; Schappet J; Breheny P; Mott SL; Bannick N; Askeland E; Brown J; Henry MD
Mol Cancer; 2015 Jul; 14():141. PubMed ID: 26220087
[TBL] [Abstract][Full Text] [Related]
14. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
[TBL] [Abstract][Full Text] [Related]
15. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
16. BRAF
Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
[TBL] [Abstract][Full Text] [Related]
17. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
18. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
[TBL] [Abstract][Full Text] [Related]
19. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
20. Human colon organoids reveal distinct physiologic and oncogenic Wnt responses.
Michels BE; Mosa MH; Grebbin BM; Yepes D; Darvishi T; Hausmann J; Urlaub H; Zeuzem S; Kvasnicka HM; Oellerich T; Farin HF
J Exp Med; 2019 Mar; 216(3):704-720. PubMed ID: 30792186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
